Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 20;9(8):e105173.
doi: 10.1371/journal.pone.0105173. eCollection 2014.

Photodynamic therapy using systemic administration of 5-aminolevulinic acid and a 410-nm wavelength light-emitting diode for methicillin-resistant Staphylococcus aureus-infected ulcers in mice

Affiliations

Photodynamic therapy using systemic administration of 5-aminolevulinic acid and a 410-nm wavelength light-emitting diode for methicillin-resistant Staphylococcus aureus-infected ulcers in mice

Kuniyuki Morimoto et al. PLoS One. .

Abstract

Bacterial resistance to antibiotics has become a worldwide problem. One potential alternative for bacterial control is photodynamic therapy. 5-aminolevulinic acid is a natural precursor of the photosensitizer protoporphyrin IX. Relatively little is known about the antibacterial efficacy of photodynamic therapy using the systemic administration of 5-aminolevulinic acid; a few reports have shown that 5-aminolevulinic acid exerts photodynamic effects on methicillin-resistant Staphylococcus aureus (MRSA) in vitro. In this study, we evaluated the effectiveness of photodynamic therapy using 5-aminolevulinic acid and a 410-nm wavelength light-emitting diode in vitro and in vivo for the treatment of MRSA. We found that 5-aminolevulinic acid photodynamic therapy with the light-emitting diode had an in-vitro bactericidal effect on MRSA. In vivo, protoporphyrin IX successfully accumulated in MRSA on ulcer surfaces after intraperitoneal administration of 5-aminolevulinic acid to mice. Furthermore, 5-aminolevulinic acid photodynamic therapy accelerated wound healing and decreased bacterial counts on ulcer surfaces; in contrast, vancomycin treatment did not accelerate wound healing. Our findings indicate that 5-aminolevulinic acid photodynamic therapy may be a new treatment option for MRSA-infected wounds.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Mouse model of MRSA-infected cutaneous ulcers.
(A) Mouse model of infected cutaneous ulcers after inoculation with MRSA. (B) Light shielding and wound protection with a bandage.
Figure 2
Figure 2. MRSA counts after PDT with 5-ALA in vitro.
(A) MRSA counts (in CFU/mL) 15 min, 4 h, and 16 h after ALA-PDT with 5 mg/mL 5-ALA and LED irradiation at 50 J/cm2. (B) MRSA counts after ALA-PDT with various 5-ALA concentrations and LED total fluencies. Data are expressed as mean ± SEM. *P<0.01.
Figure 3
Figure 3. ALA-PDT selectivity of MRSA over 3T3 cells.
In-vitro survival curves of MRSA and 3T3 cells after PDT with 5 mg/mL 5-ALA and irradiation at 0, 5, 20, and 50 J/cm2 with a 410-nm LED. Data are expressed as mean ± SEM. N = 3 in each group.
Figure 4
Figure 4. Accumulation of PpIX in MRSA after intraperitoneal injection with 5-ALA.
(A) Cutaneous skin ulcers with (right) or without (left) MRSA. (B) Strong red fluorescence was detected in MRSA-infected ulcers 24 h after intraperitoneal injection of 200 mg/kg 5-ALA and irradiation with a Wood’s lamp (right). (C) Transmission image of a smear on a cutaneous ulcer infected with MRSA after intraperitoneal injection of 5-ALA. (D) Confocal laser scanning microscopy of PpIX fluorescence in MRSA. 405-nm diode, ultraviolet light, emission bandwidth 620–650 nm.
Figure 5
Figure 5. Change in ulcer area over time after MRSA infection.
Wound healing over time in MRSA-infected or non-infected cutaneous ulcers. Each point represents the mean percentage of the area of the original wound. Data are expressed as mean ± SEM. N = 5 in each group. *P<0.01.
Figure 6
Figure 6. Change in ulcer area over time after PDT.
(A) Healing of MRSA-infected cutaneous ulcers treated with 410-nm irradiation at 50 J/cm2. (B) Wound healing over time in mice with MRSA-infected cutaneous ulcers treated with 200 mg/kg 5-ALA with or without PDT. Each point represents the mean percentage of the area of the original wound. Data are expressed as mean ± SEM. N = 5 in each group. *P<0.01.
Figure 7
Figure 7. Changes in ulcer area after VCM treatment.
Wound healing over time in PDT-treated and VCM-treated mice. Each point represents the mean percentage of the area of the original wound. Data are expressed as mean ± SEM. N = 5 in each group.
Figure 8
Figure 8. Bacterial counts in wound tissue after PDT.
Bacterial cell viability in wound tissue from PDT-treated mice (200 mg/kg 5-ALA and 50 J/cm2 irradiation) or VCM-treated mice. Data are expressed as mean ± SEM. N = 3 in each group. *P<0.01.
Figure 9
Figure 9. Gross morphology of cutaneous ulcers after PDT.
General morphologies of cutaneous ulcers were imaged on days 1, 4, 7, 10, and 13 in (A) C57BL/ksj db/db mice without MRSA, (B) C57BL/ksj db/db mice with MRSA, (C) VCM-treated mice, and (D) PDT-treated mice (200 mg/kg 5-ALA and 50 J/cm2 irradiation).

References

    1. Perichon B, Courvalin P (2004) Heterologous expression of the enterococcal vanA operon in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 48: 4281–4285. - PMC - PubMed
    1. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, et al. (1997) Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350: 1670–1673. - PubMed
    1. Sieradzki K, Roberts RB, Haber SW, Tomasz A (1999) The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 340: 517–523. - PubMed
    1. Wainwright M (1998) Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother 42: 13–28. - PubMed
    1. Maisch T (2007) Anti-microbial photodynamic therapy: useful in the future? Lasers Med Sci 22: 83–91. - PubMed

Publication types

MeSH terms

LinkOut - more resources